Belamy B. Cheung

3.6k total citations
61 papers, 1.8k citations indexed

About

Belamy B. Cheung is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Belamy B. Cheung has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 34 papers in Neurology and 16 papers in Immunology. Recurrent topics in Belamy B. Cheung's work include Neuroblastoma Research and Treatments (34 papers), Retinoids in leukemia and cellular processes (15 papers) and interferon and immune responses (11 papers). Belamy B. Cheung is often cited by papers focused on Neuroblastoma Research and Treatments (34 papers), Retinoids in leukemia and cellular processes (15 papers) and interferon and immune responses (11 papers). Belamy B. Cheung collaborates with scholars based in Australia, United States and China. Belamy B. Cheung's co-authors include Glenn M. Marshall, Murray D. Norris, Michelle Haber, Tao Liu, Daniel R. Carter, Jessica Koach, Maria Kavallaris, Jessica L. Bell, G M Marshall and Owen Tan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature reviews. Cancer.

In The Last Decade

Belamy B. Cheung

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belamy B. Cheung Australia 25 1.3k 582 479 330 289 61 1.8k
Muxiang Zhou United States 26 1.6k 1.2× 525 0.9× 97 0.2× 355 1.1× 893 3.1× 51 2.3k
Barry J. Maurer United States 17 1.0k 0.8× 151 0.3× 293 0.6× 97 0.3× 164 0.6× 40 1.3k
Valeria Masciullo Italy 25 1.5k 1.1× 361 0.6× 96 0.2× 214 0.6× 722 2.5× 53 2.5k
Weili Ma Taiwan 16 1.3k 1.0× 348 0.6× 83 0.2× 186 0.6× 986 3.4× 59 2.0k
Chia‐Lang Hsu Taiwan 25 1.1k 0.8× 480 0.8× 79 0.2× 387 1.2× 364 1.3× 118 1.8k
Katrina Diener United States 13 1.3k 1.0× 231 0.4× 85 0.2× 203 0.6× 237 0.8× 18 1.7k
Meike Vogler Germany 26 2.1k 1.6× 362 0.6× 84 0.2× 563 1.7× 769 2.7× 59 2.9k
Xiaobing Deng United States 24 1.2k 0.9× 300 0.5× 64 0.1× 195 0.6× 436 1.5× 39 1.8k
Daichao Xu China 19 1.2k 0.9× 257 0.4× 107 0.2× 533 1.6× 226 0.8× 33 1.9k
Hasem Habelhah United States 23 1.6k 1.2× 722 1.2× 46 0.1× 445 1.3× 426 1.5× 37 2.1k

Countries citing papers authored by Belamy B. Cheung

Since Specialization
Citations

This map shows the geographic impact of Belamy B. Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belamy B. Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belamy B. Cheung more than expected).

Fields of papers citing papers by Belamy B. Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belamy B. Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belamy B. Cheung. The network helps show where Belamy B. Cheung may publish in the future.

Co-authorship network of co-authors of Belamy B. Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Belamy B. Cheung. A scholar is included among the top collaborators of Belamy B. Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belamy B. Cheung. Belamy B. Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayoh, Chelsea, Katleen De Preter, Frank Speleman, et al.. (2023). MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression. Oncogene. 43(5). 363–377. 5 indexed citations
2.
Massudi, Hassina, Jessica K. Holien, Jessica Koach, et al.. (2023). Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface. Cancers. 15(6). 1822–1822.
3.
Yuan, Xiaojun, Ying Xu, Yijun Chen, et al.. (2022). Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. Cell Reports. 41(1). 111455–111455. 18 indexed citations
4.
Nagy, Zsuzsanna, William K. Chang, Chelsea Mayoh, et al.. (2021). An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. Nature Communications. 12(1). 1881–1881. 54 indexed citations
5.
Zimmerman, Mark W., Nina Weichert‐Leahey, Belamy B. Cheung, et al.. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers. 13(19). 4783–4783. 9 indexed citations
6.
Bingül, Murat, Greg M. Arndt, Glenn M. Marshall, et al.. (2021). Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer Cells. Molecules. 26(19). 5745–5745. 2 indexed citations
7.
Bingül, Murat, Greg M. Arndt, Glenn M. Marshall, et al.. (2020). Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC Inhibitors. Molecules. 25(6). 1377–1377. 4 indexed citations
8.
Ni, Jie, Belamy B. Cheung, Julia Beretov, et al.. (2020). CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo. Experimental Cell Research. 388(2). 111850–111850. 9 indexed citations
9.
Nagy, Zsuzsanna, et al.. (2020). Withaferin A activates TRIM16 for its anti-cancer activity in melanoma. Scientific Reports. 10(1). 19724–19724. 35 indexed citations
10.
Sutton, Selina K., Belamy B. Cheung, Hassina Massudi, et al.. (2019). Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis. Journal of Cancer Research and Clinical Oncology. 145(9). 2241–2250. 10 indexed citations
11.
Carter, Daniel R., Bing Liu, Chelsea Mayoh, et al.. (2018). Network Modeling of microRNA–mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN. Cancer Research. 78(12). 3122–3134. 45 indexed citations
12.
Tang, Ying, Belamy B. Cheung, Bernard Atmadibrata, et al.. (2017). The regulatory role of long noncoding RNAs in cancer. Cancer Letters. 391. 12–19. 85 indexed citations
13.
Tan, Owen, Bing Liu, Toby N. Trahair, et al.. (2016). High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Cancer Letters. 374(2). 315–323. 48 indexed citations
14.
Sutton, Selina K., Daniel R. Carter, Patrick Kim, et al.. (2016). A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. Oncotarget. 7(32). 52166–52178. 9 indexed citations
15.
Bingül, Murat, Owen Tan, Selina K. Sutton, et al.. (2016). Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety. Molecules. 21(7). 916–916. 66 indexed citations
16.
Cheung, Belamy B.. (2015). Combination therapies improve the anticancer activities of retinoids in neuroblastoma. World Journal of Clinical Oncology. 6(6). 212–212. 15 indexed citations
17.
Beckers, Anneleen, Andrew D. Ludwig, Gert Van Peer, et al.. (2014). The MYCN/miR-26a-5p/LIN28B regulatory axis controls MYCN-driven LIN28B upregulation in neuroblastoma. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
18.
Marshall, Glenn M., Daniel R. Carter, Belamy B. Cheung, et al.. (2014). The prenatal origins of cancer. Nature reviews. Cancer. 14(4). 277–289. 184 indexed citations
19.
Cheung, Belamy B., Jessica L. Bell, Jessica Koach, et al.. (2009). ATP7A is a novel target of retinoic acid receptor β2 in neuroblastoma cells. British Journal of Cancer. 100(1). 96–105. 21 indexed citations
20.
Liu, Tao, Stewart A. Smith, Belamy B. Cheung, et al.. (2005). The retinoid anticancer signal: mechanisms of target gene regulation. British Journal of Cancer. 93(3). 310–318. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muxiang Zhou Breakdown of academic impact, for papers by Barry J. Maurer Breakdown of academic impact, for papers by Valeria Masciullo Breakdown of academic impact, for papers by Weili Ma Breakdown of academic impact, for papers by Chia‐Lang Hsu Breakdown of academic impact, for papers by Katrina Diener Breakdown of academic impact, for papers by Meike Vogler Breakdown of academic impact, for papers by Xiaobing Deng Breakdown of academic impact, for papers by Daichao Xu Breakdown of academic impact, for papers by Hasem Habelhah
Rankless by CCL
2026